A new industrial-type special economic zone (SEZ), Bolshoy Serpukhov, will be established in the Moscow Region, as a resolution prepared by the Ministry of Economic Development was approved by the Government of the Russian Federation. Seven investment projects are planned, including the production of medicines, with the total investment volume exceeding 8 billion rubles.
The creation of the Bolshoy Serpukhov SEZ is expected to create nearly 900 jobs. Among other initiatives, investors aim to launch the production of medicines, develop a system for disinfection and sterilization of medical devices, and create domestic equipment for DNA research.
According to the accompanying documents for the draft resolution, at least six investment projects are set to enter the new SEZ. AO Aluron will build a production complex for Tameron, an immunomodulator, and Myodystrophin, a therapy for Duchenne muscular dystrophy. Another company, AO Stoletika, will develop Argos Cold Plasma Generator, a medical device.
OOO MedSystem will produce the GastroClean system for disinfecting and sterilizing endoscopes, and OOO AxioPharm will create an artificial nerve conduit for neurosurgery based on a biocompatible nanomaterial. OOO Nanoporus is to create equipment and consumables for nanopore sequencing of DNA, RNA, and proteins.
AO NPO Otechestvennye Tekhnologii will develop systems to ensure a comfortable microclimate for specialists working at low temperatures.
By 2035, the SEZ is expected to generate tax and other revenues totaling 3.8 million rubles. Over a decade, the investment volume from potential resident companies within the SEZ is estimated at 8 million rubles, with revenue from the sale of goods, works, and services projected to reach at least 35.67 million rubles.
In 2024, it was announced that a new workshop for medicine production is being constructed in Bolshoy Serpukhov. Aluron was in charge of the implementation of the project. The site will manufacture Myodystrophin, Tameron, and Nanoporus, according to earlier reports. The production of Nanoporus will involve producing equipment, consumables, and software for nanopore sequencing of DNA, RNA, and proteins.
